IRIS
CASTAGNA, ANTONELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.887
NA - Nord America 2.194
AS - Asia 1.874
SA - Sud America 40
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 5
Totale 7.032
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.168
SE - Svezia 1.378
CN - Cina 1.035
SG - Singapore 723
RU - Federazione Russa 578
IT - Italia 544
FI - Finlandia 155
DE - Germania 68
IE - Irlanda 54
IN - India 43
BR - Brasile 30
GB - Regno Unito 23
NL - Olanda 20
FR - Francia 19
IR - Iran 15
CA - Canada 13
EU - Europa 11
MX - Messico 10
HK - Hong Kong 8
PH - Filippine 8
ID - Indonesia 7
JP - Giappone 7
ES - Italia 6
KR - Corea 6
PK - Pakistan 6
NG - Nigeria 5
TR - Turchia 5
UA - Ucraina 5
AR - Argentina 4
AT - Austria 4
AU - Australia 4
DK - Danimarca 4
EG - Egitto 4
MD - Moldavia 4
NO - Norvegia 4
BE - Belgio 3
CZ - Repubblica Ceca 3
HR - Croazia 3
RO - Romania 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
CL - Cile 2
DO - Repubblica Dominicana 2
MW - Malawi 2
TH - Thailandia 2
TN - Tunisia 2
BG - Bulgaria 1
BO - Bolivia 1
CO - Colombia 1
EC - Ecuador 1
ET - Etiopia 1
GH - Ghana 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
ME - Montenegro 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PL - Polonia 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TZ - Tanzania 1
ZM - Zambia 1
Totale 7.032
Salva come PNG Salva come JPEG
Città #
Lawrence 542
Princeton 542
Shenzhen 433
Singapore 424
Moscow 288
Shanghai 223
Milan 219
New York 206
Ashburn 188
Helsinki 133
Boardman 101
Dublin 51
Rome 44
Guangzhou 39
Washington 33
Pune 30
Dallas 26
Seattle 25
Beijing 24
Lappeenranta 19
Los Angeles 16
Genoa 14
St Petersburg 14
Borås 10
Quanzhou 10
Jiaxing 9
Santa Clara 9
São Paulo 9
Xi'an 9
Gatchina 8
Hanover 8
Padova 8
Wuxi 8
Bologna 7
Perm 7
Pisa 7
Busto Arsizio 6
Florence 6
Lahore 6
Paris 6
Turin 6
Campodolcino 5
Clifton 5
Iztapalapa 5
Kassel 5
Maringá 5
Mexico City 5
Munich 5
Vittoria 5
Yekaterinburg 5
Yongin-si 5
Amsterdam 4
Chisinau 4
Ferrara 4
Fremont 4
Hyderabad 4
Jakarta 4
Liverpool 4
Madrid 4
Monsummano Terme 4
Nizhniy Novgorod 4
Quezon City 4
Sydney 4
Taizhou 4
Trondheim 4
West Jordan 4
Wuyuan 4
Angera 3
Athens 3
Ballincollig 3
Brescia 3
Cernusco sul Naviglio 3
Cesano Boscone 3
Chengdu 3
Curitiba 3
Durban 3
Espoo 3
Fuzhou 3
Guardiagrele 3
Hong Kong 3
Lviv 3
Messina 3
Nuremberg 3
Ostuni 3
Pioltello 3
Rockville 3
Segrate 3
Vancouver 3
Voronezh 3
Zagreb 3
Al Mansurah 2
Andover 2
Anzio 2
Aversa 2
Basiano 2
Berlin 2
Bibiana 2
Blantyre 2
Boltiere 2
Boston 2
Totale 3.976
Salva come PNG Salva come JPEG
Nome #
Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population 419
Impact of Levofloxacin for Prophylaxis of Pre-engraftment Bloodstream Infections after Allogeneic HSCT: A single-center Matched Analysis in an Endemic Country for Carbapenem-resistant Gram-negative Bacteria 65
Viral bloodstream detection in mpox patients: An observational multicentric study 64
Week 96 safety and efficacy of the novel HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced participants infected with multi-drug resistant HIV-1 (BRIGHTE study) 54
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 49
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia 49
The 118I reverse transcriptase mutation is the only independent genotypic predictor of virologic failure to a stavudine-containing salvage therapy in HIV-1-infected patients 47
Gas-exchange deficit and systemic hypoperfusion in COVID-19 and non-COVID-19 young adult patients with pneumonia 46
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency 44
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 42
Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study 40
Continuous positive airway pressure and pronation outside the Intensive Care Unit in COVID-19 acute respiratory distress syndrome 38
Testosterone in males with COVID-19: A twelve-month cohort study 34
Failure of on-demand pre-exposure prophylaxis: the risk of HIV drug resistance 33
Combined plasma levels of IL-10 and testosterone, but not soluble HLA-G5, predict the risk of death in COVID-19 patients 32
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 32
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 32
Response to combination antiretroviral therapy: Variation by age 31
Biobanking for COVID-19 research 30
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 29
Brief Report: Association Between Low HIV-1 DNA and Western Blot Reactivity to HIV-1 Pol in Chronically Infected Individuals 29
T and B cell responses to cytomegalovirus antigens in healthy blood donors and bone marrow transplant recipients 29
Subclinical myocardial dysfunction in patients recovered from COVID-19 29
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia 28
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 28
Changes in homeostatic model assessment for insulin resistance (HOMA-IR) index in treated HIV-1 infected people on virological suppression who switched to a different antiretroviral regimen 27
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 27
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study 26
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase 26
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses 25
Pulmonary Vascular Thrombosis in COVID-19 Pneumonia 25
PS1268 CEFTAZIDIME/AVIBACTAM AND CEFTOLOZANE/TAZOBACTAM FOR THE TREATMENT OF FEBRILE NEUTROPENIA IN ALLOGENEIC TRANSPLANT RECIPIENTS 25
Severely low testosterone in males with COVID-19: a case-control study 25
VIRO-immunological outcomes after 13-valent pneumococcal vaccination in HIV-1-infected individuals on stable virological suppression 24
Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrier 24
A comparision of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patients 24
Efficacy and Safety Profile of Fostemsavir for the Treatment of People with Human Immunodeficiency Virus-1 (HIV-1): Current Evidence and Place in Therapy 24
Symptoms and signs of conjunctivitis as predictors of disease course in COVID-19 syndrome 24
What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centres 23
Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial 23
Cerebrospinal fluid viral replication and burden of resistance in three HIV-1-infected people taking Ibalizumab with multiple drug class-wide resistance 23
HIV-DNA undetectability during chronic HIV infection: Frequency and predictive factors 23
Western blot in treated people with HIV-1 chronic infection: frequency of negative HIV-1 pol genes 23
Circulating cathodic antigen (CCA) urine rapid test for diagnosis of Schistosoma mansoni infestation: preliminary data of a cohort study of Egyptian patients coming from an endemic area 23
Serum IgG1 and IgG4 could contribute to partial control of viral rebound in chronically HIV-1-infected patients 23
Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultation 22
A follow-up study in asymptomatic HIV patients 22
LC-MS/MS method for simultaneous determination of linezolid, meropenem, piperacillin and teicoplanin in human plasma samples 22
Analytical treatment interruption in chronic HIV-1 infection: Time and magnitude of viral rebound in adults with 10 years of undetectable viral load and low HIV-DNA (APACHE study) 22
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study) 22
Dynamics of HIV-1 POL antibodies after ART in chronic HIV-1 infection 22
Beyond stigma: Monkeypox infection in a 27-year-old woman 21
Post-neurosurgical Nocardia meningoventriculitis: a case report and review of the literature 21
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study 21
INCREASED RISK OF DEATH AMONG HIV/HCV CO-INFECTED PATIENTS WITH NON-HODGKIN'S LYMPHOMA 21
Rugarli. Medicina interna sistematica 21
Anti-HIV antibodies are representative of the latent reservoir but do not correlate with viral control in people with long-lasting virological suppression undergoing analytical treatment interruption (APACHE study) 21
Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium 21
Meningococcus B Vaccination Effectiveness Against Neisseria gonorrhoeae Infection in People Living With HIV: A Case-Control Study 21
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation 20
Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients 20
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 20
Switching antiretrovirals in older patients 20
Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study 20
Retrospective study on the outcome of two-drug regimens based on dolutegravir plus one reverse transcriptase inhibitor in virologically-suppressed HIV-infected patients 20
SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic 20
Prior Neisseria meningitidis (Nm) proctitis does not prevent Neisseria gonorrhoeae (Ng) proctitis among men who have sex with men (MSM) 19
Cardiac implantable electronic device infections: impact of initiation of antimicrobial treatment before or after device removal on microbiological yield 19
Longitudinal evaluation of occult Hepatitis B infection in HIV-1 infected individuals during highly active antiretroviral treatment interruption and after HAART resumption 19
Short-term efficacy and safety of betamethasone valerate 2.25 mg medicated plaster in patients with chronic lateral epicondylitis: Results of a randomised, double blind, placebo-controlled study 19
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study 19
Role of blood pressure dysregulation on kidney and mortality outcomes in COVID-19. Kidney, blood pressure and mortality in SARS-CoV-2 infection 19
Myocardial injury in patients with SARS-CoV-2 pneumonia: pivotal role of inflammation in COVID-19 19
Factors Associated with Health Care Providers' Preference for Forgoing an Oral Lead-In Phase When Initiating Long-Acting Injectable Cabotegravir and Rilpivirine in the SOLAR Clinical Trial 18
Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice 18
Cerebrospinal fluid beta 2-microglobulin in AIDS related central nervous system involvement. 18
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection 18
Zidovudine and frequency of HIV-induced diffuse leukoencephalopathy 18
Therapeutic trials with HPA23, alpha-IFN and ribavirin in AIDS patients 18
Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study 18
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus 18
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 18
Atazanavir/ritonavir monotherapy: 96 week efficacy, safety and bone mineral density from the MODAt randomized trial 18
Rhodococcus defluvii pneumonia: First reported case in humans 18
COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike Receptor Binding Domain 18
Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: A Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians 18
Infections after Allogenic Transplant with Post-Transplant Cyclophosphamide: Impact of Donor HLA Matching 18
Erratum: Correction to: Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIV (BMC infectious diseases (2021) 21 1 (557)) 18
Ribavirin Aerosol in the Treatment of SARS-CoV-2: A Case Series 18
Neutralizing monoclonal antibodies for the treatment and prophylaxis of SARS-CoV-2 infection 18
Treatment success of rescue regimens after dual therapy failure in people living with HIV in a real-life setting 18
Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort 18
The propensity for long-acting cabotegravir and rilpivirine every 2 months among HIV-infected people eligible for treatment 17
Probable West Nile Virus hepatitis: Case report 17
Profiling Covid-19 patients with respect to level of severity: an integrated statistical approach 17
Monkeypox infection in a hemopoietic stem cell and heart transplant recipient 17
In vivo dynamics of the 103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in HIV-infected patients: Preliminary results 17
Clinical and immunological aspects of HIV infection in drug addicts 17
A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients: the MaxCmin2 trial 17
Key questions in antiretroviral therapy: Italian Consensus Workshop (2005) 17
Totale 2.891
Salva come PNG Salva come JPEG
Categoria #
all - tutte 140.374
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 140.374
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 0 0 0 0 1 1
2020/2021235 2 0 1 23 0 51 11 131 5 0 7 4
2021/2022417 1 0 0 137 26 29 36 64 36 29 16 43
2022/20232.833 1.206 552 220 27 36 257 174 185 98 19 35 24
2023/20242.159 45 66 641 171 178 408 59 180 8 45 113 245
2024/20251.900 1.077 150 178 281 214 0 0 0 0 0 0 0
Totale 7.974